Viewing StudyNCT00272662

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00272662
Status: COMPLETED
Last Update Posted: 2012-12-21
First Post: 2006-01-05
Brief Title: Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
Sponsor: Affymax
Organization: Affymax
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Cancer
Chemotherapy Induced Anemia
Keywords:
Name View
red blood cell production View
anemia View
cancer View
chemotherapy View
chemotherapy induced anemia View
CIA View
hemoglobin View
Hb View
Hgb View
erythropoietin View
EPO View
erythropoiesis stimulating agent View
ESA View
Hematide View
Omontys View
peginesatide View
red blood cell View